ARBUTUS BIOPHARMA CORP (ABUS:NASDAQ)
$4.17 0.02 (0.4819%)
Analysed ARBUTUS BIOPHARMA CORP (ABUS:NASDAQ) News Sources
Arbutus: Q4 Earnings Snapshot
23-03-2026
yahoo.com
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
23-03-2026
yahoo.com
Moderna Settlement And EMA Opinion Reframe mRNA Platform Outlook
07-03-2026
yahoo.com
Moderna (MRNA) Climbs 16% as Arbutus-Genevant Legal Battle Clears
05-03-2026
yahoo.com
Does $2.25 Billion LNP Settlement And Global License Reshape The Bull Case For Moderna (MRNA)?
04-03-2026
yahoo.com
Why Moderna (MRNA) Stock Is Trading Up Today
04-03-2026
yahoo.com
These Stocks Are Today’s Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More
04-03-2026
yahoo.com
Moderna Stock Shoots Up on $2.3 Billion Patent Settlement
04-03-2026
yahoo.com
US Equity Markets End Higher After Strong Services, Jobs Data
04-03-2026
yahoo.com
Moderna Stock Pops After Inking $950 Million Covid Vaccine Settlement
04-03-2026
yahoo.com
What is the current price of ARBUTUS BIOPHARMA CORP (ABUS:NASDAQ)?
The current price of ARBUTUS BIOPHARMA CORP (ABUS:NASDAQ) is $4.17.
ARBUTUS BIOPHARMA CORP (ABUS:NASDAQ) absolute price change since previous trading day?
The absolute price change of ARBUTUS BIOPHARMA CORP (ABUS:NASDAQ) since the previous trading day is $0.02.
ARBUTUS BIOPHARMA CORP (ABUS:NASDAQ) percentage price change since previous trading day?
The percentage price change of ARBUTUS BIOPHARMA CORP (ABUS:NASDAQ) since the previous trading day is 0.4819%.
What is the most recent average sentiment score for ARBUTUS BIOPHARMA CORP (ABUS:NASDAQ)?
The most recent average sentiment score for ARBUTUS BIOPHARMA CORP (ABUS:NASDAQ) is 38 out of 100.
What is the most recent average sentiment for ARBUTUS BIOPHARMA CORP (ABUS:NASDAQ)?
The most recent sentiment for ARBUTUS BIOPHARMA CORP (ABUS:NASDAQ) is .
SEC-8K** Filing Available For ARBUTUS BIOPHARMA CORP (ABUS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.